Dental Standards & Testing Methods

Slides:



Advertisements
Similar presentations
Regulatory Pathway for Platform Technologies
Advertisements

Entering the US Market: Medical Devices
Overview of Device Regulations David Arvelo Small Business Representative.
Introduction to Dental Materials
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Development of ISO standards for AD syringes SIGN Meeting Cambodia, October 2002 Injection technologies G Gerald Verollet.
510k Submission Overview Myraqa, Inc. August 22, 2012.
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
Chapter 22 Regulatory & Advisory Agencies Copyright 2003, Elsevier Science (USA). All rights reserved. No part of this product may be reproduced or transmitted.
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Medical Devices Approval Process
Regulatory Issues US and Abroad BIT 230 Chapters 9-11 Huxsoll.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Harmonization of Standards for Assistive Technology (AT) Rory A. Cooper, Ph.D. Departments of Rehabilitation Science & Technology, and Bioengineering University.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Introduction to Dental Materials Chapter 1. What Is “Dental Materials”? “Dental Materials” is defined as the study and science of the development, properties,
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 3 Drug Regulation, Development, Names, and Information.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Revision of the Medical Device Directives The case of ‘Borderline’ Products used in a self-care context 48th AESGP Annual Meeting Nice, 6-8 June 2012 Laurent.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
Federal Laws CHAPTER 3. DRUG REGULATION Timeline highlights –Food Drug & Cosmetic (FDC) Act –Durham Humphrey Amendment –Poison Prevention Packaging Act.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
FDA Focus On Consumer Protection
How to Register A Foreign Medical Device. SFDA Approval Documents Preparation Translation Create a Chinese Registration Standard Safety Testing in an.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
Center for Drug Evaluation and Research (CDER) Tanya Eberle Kamal Diar David Clements.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
History of Pediatric Labeling
FDA Office of Orphan Products Development
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
July 15, Postmarketing Safety Evaluation of Approved Drugs and Risk Management Victor F. C. Raczkowski, MD, MS Director, Office of Drug Safety July.
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.
COPYRIGHT ALL RIGHTS RESERVED. LEGAL DISCLOSURE. November 25, 2002 PRESENTATION TO: Public Hearing: FDA Regulation of Combination Products November.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
Regulation of Generic Animal Drugs in the United States
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.
Clinical Trials.
By Dr.Reham Mohammed Abdallah. Science of dental materials  Is defined as; compositionproperties manner in which they interact with the environment “The.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 3 Drug Regulation, Development, Names, and Information.
Chapter 22 REGULATORY AND ADVISORY AGENCIES. Introduction 2.
FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.
Contingent Workforce: Cerner Quality System & Regulations
Use of Postmarket Data to Support Premarket Approvals
The Professional Dental Assistant
66 items – 70% of circulated products
Biotechnology R&D.
Premarket Notification 510(k) process
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
The Current PMA Requirements
Clinical Trials Medical Interventions
Generic Medicines.
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
Bozeman Health Clinical Research
Clinical Trials.
Suzanne M. Sensabaugh, MS, MBA
Opening an IND: Investigator Perspective
Objective 2 Biomedical Research Methods
Introduction to Basic Research Methods
Care of Research Animals
Presentation transcript:

Dental Standards & Testing Methods

Types of tests for biomaterials Lab Tests Clinical Tests

Clinical Tests – Advantages: simulates the temperature, humidity, and fluid in the environment simulates the mechanical forces exerted during mastication

Clinical Tests – Disadvantages: patients highly variable – need large numbers: cost specimens often not recoverable studies take a very long time: cost results may be skewed toward making the material look good

Clinical Tests – Sources of bias: patient selection skilled operators study environment – University practices may not simulate typical dental practices desire to please corporate sponsors

Laboratory Testing – advantages: quicker and consequently cheaper specimens can be recovered no danger to patients or animals testing conditions are repeatable – patient variability is not a factor

Laboratory Testing – disadvantages: correct mechanical conditions are difficult to know correct testing environment (temperature, saliva chemistry, pH, etc.) is difficult to know

Laboratory Testing – two types of tests: use tests try to simulate oral conditions (e.g., cyclic testing, 37oC, artificial saliva, etc.) abuse tests exaggerate clinical conditions – try to quickly produce results that predict long-term durability of materials

1920 U.S. Army supports Wilmer Souder at the Nat’l Bureau of Standards US Standards: 1920 U.S. Army supports Wilmer Souder at the Nat’l Bureau of Standards 1920-28 Weinstein Fellowships at the NBS

US Standards: 1928 - ADA Fellowships support research at the NBS Over 20 Specifications are developed 1966 - ADA establishes Council on Dental Materials & Devices. More recently this council was merged with others to become the ADA’s Council on Scientific Affairs

American National Standards Institute Has assigned the ADA to administer American National Standards Institute These specification consist of packaging and labeling requirements and laboratory tests that the product must pass. Clinical efficacy is NOT evaluated.

ADA Seal of Acceptance: Covers drugs, therapeutic agents, and materials: 1300 products currently carry the seal 30% sold to consumers 70% sold only to dentists The ADA Seal Program for professional products has been phased out. It ended completely on 12/31/07. The Seal Program on consumer products will continue.

after 2007 no longer covers professional products

ADA Professional Product Review a quarterly insert that is included with the Journal of the Americans Dental Association quantitative laboratory data on materials are reported qualitative practitioner data is reported replaces acceptance program (seal program), which was increasingly being ignored by both practitioners and manufacturers.

U.S. regulation of dental materials: Some dental materials are regulated as “medical devices” by the Food & Drug Administration (FDA). Medical Device Amendments of 1976

U.S. regulation of dental materials: To administer the Medical Device Amendments the FDA: Set up 19 panels One panel was the Panel on Review & Classification of Dental Devices

U.S. regulation of dental materials: Three classes of devices: Class I General controls Class II Performance Standards Class III Premarket Approval Unclassified devices are treated as Class II devices

U.S. regulation of dental materials: General controls (Class I): Ensure compliance with Good Manufacturing practices Premarket notification (510K) Class I: burs, preformed crowns, porcelain teeth

U.S. regulation of dental materials: Performance Standards (Class II): Ensure compliance with Good Manufacturing practices Premarket notification (510K), but includes requirement to demonstrate “substantial equivalence” with existing products Postmarket surveillance, patient registries Class II: resin composites, impression materials, calcium hydroxide liners

U.S. regulation of dental materials: Performance Standards (Class II): “Substantial equivalence” can be demonstrated by compliance with recognized standards The FDA has recognized 27 SCDP standards and 30 ISO standards

U.S. regulation of dental materials: Premarket Approval (Class III): Preamendment devices (on the market before 1976) – no premarket approval is required PMA devices – materials that have a new use or greatly different composition will usually be classified as Class III requiring premarket approval

U.S. regulation of dental materials: Premarket approval involves: Laboratory tests Preclinical studies (animal studies) Clinical evidence of safety and effectiveness (expensive, time consuming)

International standards: Federation Dentaire Internationale (FDI) – federation made up of national dental associations Administers dental international standards for the ISO (International Organization for Standardization) Technical committee in Dentistry – ISO / TC 106

International standards: ISO / TC 106 Currently has 145 approved standards (2005, up from 105 in 1999) Lab tests only (like ADA SCDP standards)

International standards: CEN (Comité Européen de Normalization); Task Group 55 charged to develop European standards for dental materials, instruments, & equipment CEN mark – products must have to sell in Europe CEN usually adopts ISO dental standards NOTE: Unlike U.S. standards, these standards are NOT voluntary. U.S. dentists benefit because manufacturers who want to sell in Europe (just about all manufacturers) must get the CEN mark.

The End